Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Experimental therapies for Parkinson's disease: Why fake it?

Nature volume 476, pages 142–144 (2011)Cite this article

Subjects

How 'sham' brain surgery could be killing off valuable therapies for Parkinson's disease.

Peggy Willocks was 44 when she was diagnosed with Parkinson's disease. It progressed quickly, forcing her to retire four years later from her job as a primary-school principal in Elizabethton, Tennessee. Soon, her condition had deteriorated so much that she was often unable to dress and feed herself, take care of basic hygiene or walk unaided across a room.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. Stover, N. P. & Watts, R. L. Neurotherapeutics 5, 252-259 (2008).

    Article  CAS  Google Scholar 

  2. Gross, R. E. et al. Lancet Neurol. 10, 509-519 (2011).

    Article  Google Scholar 

  3. Madrazo, I. et al. N. Engl. J. Med. 316, 831-834 (1987).

    Article  CAS  Google Scholar 

  4. Marks, W. J. et al. Lancet Neurol. 9, 1164-1172 (2010).

    Article  CAS  Google Scholar 

  5. Freed, C. R. et al. N. Engl. J. Med. 344, 710-719 (2001).

    Article  CAS  Google Scholar 

  6. Olanow, C. W. et al. Ann. Neurol. 54, 403-414 (2003).

    Article  Google Scholar 

  7. Marks, W. J. et al. Lancet Neurol. 7, 400-408 (2008).

    Article  Google Scholar 

  8. Gill, S. S. et al. Nature Med. 9, 589-595 (2003).

    Article  CAS  Google Scholar 

  9. Lang, A. E. et al. Ann. Neurol. 59, 459-466 (2006).

    Article  CAS  Google Scholar 

  10. Kim, S. Y. H. et al. Arch. Neurol. 62, 1357-1360 (2005).

    Article  Google Scholar 

  11. de la Fuente-Fernández, R. et al. Science 293, 1164-1166 (2001).

    Article  Google Scholar 

  12. McRae, C. et al. Arch. Gen. Psychiatry 61, 412-420 (2004).

    Article  Google Scholar 

  13. Politis, M. et al. Sci. Transl. Med. 2, 38ra46 (2010).

    Article  Google Scholar 

  14. Kaplitt, M. G. et al. Lancet 369, 2097-2105 (2007).

    Article  CAS  Google Scholar 

  15. LeWitt, P. A. et al. Lancet Neurol. 10, 309-319 (2011).

    Article  CAS  Google Scholar 

Download references

Authors
  1. Alla Katsnelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Alla Katsnelson is a freelance science writer in New York City.

Related links

Related links

Related links in Nature Research

Outlook: Parkinson's Disease

Related external links

Roger Barker

Parkinson Pipeline Project

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Katsnelson, A. Experimental therapies for Parkinson's disease: Why fake it?. Nature 476, 142–144 (2011). https://doi.org/10.1038/476142a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/476142a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing